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PREAMBLE
The present document is an Expert Consensus Document
that includes evidence about the standards for the acquisi-
tion, measurement, and reporting of intravascular ultra-
sound studies (IVUS). This document is intended to inform
practitioners, payers, and other interested parties of the
opinion of the American College of Cardiology (ACC)
concerning evolving areas of clinical practice and/or tech-
nologies that are widely available or new to the practice
community. Topics chosen for coverage by Expert Consen-
sus Documents are so designed because the evidence base
and experience with technology or clinical practice are not
considered sufficiently well developed to be evaluated by the
formal ACC/American Heart Association (AHA) Practice
Guidelines process. Often, the topic is the subject of
considerable ongoing investigation. Thus, the reader should
view the Expert Consensus Document as the best attempt
of the ACC to inform and guide clinical practice in those
areas where rigorous evidence may not yet be available or the
evidence to date is not widely accepted. When feasible,
Expert Consensus Documents include indications or con-
traindications. Some topics covered by Expert Consensus
Documents will be addressed subsequently by the ACC/
AHA Practice Guidelines Committee.
The Task Force on Clinical Expert Consensus Docu-
ments makes every effort to avoid any actual or potential
conflicts of interest that might arise as a result of an outside
relationship or personal interest of a member of the writing
panel. Specifically, all members of the writing panel are
asked to provide disclosure statements to inform the writing
effort of all such relationships that might be perceived as real
or potential conflicts of interest.
Robert A. O’Rourke, MD, FACC
Chair, ACC Task Force on
Clinical Expert Consensus Documents
I. INTRODUCTION
A. Organization of Committee and Evidence Review
The committee consisted of acknowledged experts in IVUS
representing the ACC (10 members) and the European
Society of Cardiology (2 members). Both the academic and
private practice sectors were represented. The document was
reviewed by four official reviewers nominated by the ACC,
four reviewers representing the ACC Board of Governors
and providing a practice perspective; seven content review-
ers nominated by the Writing Committee, the ACC Car-
diac Catheterization and Intervention Committee and Car-
diovascular Imaging Committee, and two organizations—
the European Society of Cardiology and the Society of
Cardiac Angiography and Interventions. The document was
approved for publication by the ACC Board of Trustees on
January 9, 2001, and endorsed by the European Society of
Cardiology and the Society of Cardiac Angiography and
Interventions. This document will be considered current
unless the Task Force revises or withdraws it from distri-
bution.
B. Purpose of This Document
During the past decade, IVUS has become increasingly
important in both clinical and research applications (1–6).
However, it evolved without existing standards for the
acquisition of studies, the measurement of images, and the
reporting of results. The lack of standards has affected the
ability of clinicians to communicate findings using a com-
mon language. Similarly, the literature has been confounded
by ambiguous terminology and various alternative synonyms
for similar structures and measurements. Accordingly, the
current expert consensus committee was commissioned by
the ACC, in collaboration with the European Society of
Cardiology, to provide a framework for standardization of
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nomenclature, methods of measurement, and reporting of
IVUS results. The committee has sought to provide a logical
and consistent approach to IVUS analysis in order to assist
both clinicians and investigators.
II. PHYSICAL PRINCIPLES OF IVUS IMAGING
Medical ultrasound images are produced by passing an
electrical current through a piezoelectric (pressure-electric)
crystalline material (usually a ceramic) that expands and
contracts to produce sound waves when electrically excited.
After reflection from tissue, part of the ultrasound energy
returns to the transducer, which produces an electrical
impulse that is converted into the image. The beam remains
fairly parallel for a distance (near field) and then begins to
diverge (far field). The quality of ultrasound images is
greater in the near field because the beam is narrower and
more parallel, the resolution greater, and the characteristic
backscatter (reflection of ultrasound energy) from a given
tissue more accurate. The length of the near field is
expressed by the equation L 5 r2 /l, where L is the length
of the near field, r is the radius of the transducer, and l is
the wavelength. Therefore, larger transducers with lower
frequencies are used for examination of large vessels to
extend the near field into the region of diagnostic interest.
Image quality can be partially described by two important
factors: spatial resolution and contrast resolution. The ability
to discriminate small objects within the ultrasound image
(spatial resolution) has two principal directions: axial (paral-
lel to the beam—primarily a function of wavelength) and
lateral (perpendicular to both the beam and the catheter—a
function of wavelength and transducer size, or aperture. For
a 20 to 40 MHz IVUS transducer, the typical resolution is
80 microns axially and 200 to 250 microns laterally. Contrast
resolution is the distribution of the gray scale of the reflected
signal and is often referred to as dynamic range. An image
of low dynamic range appears as black and white with a few
in-between gray scale levels; images at high dynamic range
are often softer, with preserved subtleties in the image
presentation.
As an ultrasound pulse encounters a boundary between
two tissues—fat and muscle, for instance—the beam will be
partially reflected and partially transmitted. The degree of
reflection depends on the difference between the mechanical
impedance of the two materials. For example, imaging of
highly calcified structures is associated with acoustic shad-
owing: nearly complete reflection of the signal at the soft
tissue/calcium interface. As the wave passes through many
tissue interfaces, the energy is attenuated (reduced). Atten-
uation is a function of the tissue characteristics, the scatter-
ing of energy by small objects, and the absorption by tissue.
Thus, only a small percentage of the emitted signal returns
to the transducer. The received signal is converted to
electrical energy and sent to an external signal processing
system for amplification, filtering, scan-conversion, user-
controlled modification, and finally, graphic presentation.
III. EQUIPMENT FOR IVUS EXAMINATION
There are two different types of IVUS transducers: the
mechanically rotating transducer and the electronically
switched multi-element array system. The first design is
referred to as a “mechanical IVUS system,” and the latter a
“solid-state design IVUS system.”
A. Mechanical Systems
A single rotating transducer is driven by a flexible drive
cable at 1,800 rpm (30 revolutions per second) to sweep a
beam almost perpendicular to the catheter. At approxi-
mately 1° increments, the transducer sends and receives
ultrasound signals. The time delay and amplitude of these
pulses provide 256 individual radial scans for each image.
Mechanical transducer catheters require flushing with saline
to provide a fluid pathway for the ultrasound beam, because
even small air bubbles can degrade image quality. In most
mechanical systems, the transducer spins within a protective
sheath while the imaging transducer is moved proximally
and distally. This facilitates smooth and uniform mechani-
cal pullback.
B. Electronic Systems
Electronic systems use an annular array of small crystals
rather than a single rotating transducer. The array can be
programmed so that one set of elements transmits while a
second set receives simultaneously. The coordinated beam
generated by groups of elements is known as a synthetic
aperture array. The image can be manipulated to focus
optimally at a broad range of depths. The currently available
electronic system provides simultaneous colorization of
blood flow.
IV. IVUS ARTIFACTS
A. Non-Uniform Rotational
Distortion (NURD) and Motion Artifacts
Non-uniform rotational distortion is unique to mechanical
catheter systems and results from mechanical binding of the
drive cable that rotates the transducer (7). This can occur for
a number of reasons, including the presence of acute bends
in the artery, tortuous guide catheter shapes, variance in
manufacturing of the hub or driveshaft, excessive tightening
of a hemostatic valve, kinking of the imaging sheath, or too
small a guide catheter lumen. In an extreme situation,
fracture of the drive cable can occur.
A distinct motion artifact can result from nonstable
catheter position. Occasionally, the vessel moves before a
complete circumferential image can be created. This results
in cyclic deformation of the image.
In addition, both mechanical and solid state transducers
can move as much as 5 mm between diastole and systole.
This can preclude accurate assessment of arterial phenom-
ena that depend on the cardiac cycle (i.e., arterial pulsation
and compliance).
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B. Ring-Down, Blood Speckle, and Near Field Artifacts
Ring-down artifacts are usually observed as bright halos of
variable thickness surrounding the catheter. They are pro-
duced by acoustic oscillations in the transducer, which result
in high-amplitude ultrasound signals that obscure the area
immediately adjacent to the catheter. Ring-down artifacts
are present in all medical ultrasound devices and create a
zone of uncertainty adjacent to the transducer surface.
Although time gain compensation (TGC) can be used to
decrease this artifact, excessive ring-down suppression can
reduce signals from true targets. In the solid state systems,
the transducers are surface mounted, and ring-down is
partially reduced by digital subtraction of a reference mask.
If it is incorrectly performed, digital subtraction has the
potential to remove real information or introduce false
targets.
The intensity of the blood speckle increases (exponential-
ly) as transducer frequency is increased and as blood flow
velocity decreases. This phenomenon can limit the ability to
differentiate lumen from tissue (especially soft plaque, neo-
intima, and thrombus). This problem is exacerbated by flow
stagnation or rouleaux formation, often most evident when
the catheter is across a tight stenosis or within certain
dissections (e.g., intramural hematomas). As with ring-
down suppression, TGC manipulation to reduce blood
speckle can reduce signals from real targets. Some operators
flush contrast or saline through the guiding catheter to clear
the lumen and help identify tissue borders. Computer-based
imaging algorithms can also suppress or differentiate blood
speckle from tissue.
C. Obliquity, Eccentricity,
and Problems of Vessel Curvature
Current imaging techniques assume that the vessel is
circular, the catheter is located in the center of the artery,
and the transducer is parallel to the long axis of the vessel.
However, both transducer obliquity and vessel curvature can
produce an image giving the false impression that the vessel
is elliptical. Transducer obliquity is especially important in
large vessels and can result in an overestimation of dimen-
sions and a reduction in image quality (8). The latter
phenomenon occurs because the amplitude of the echo
reflected from an interface depends, in part, on the angle at
which the beam strikes the interface. The strongest signals
are obtained when the catheter is coaxial within the vessel
and when the beam strikes the target at a 90° angle.
Therefore, lower image quality and errors in interpretation
are more likely when the IVUS catheter is not parallel to the
vessel wall.
D. Problem of Spatial Orientation
There is no absolute anterior, posterior, left and right
orientation possible in IVUS images. However, with some
systems, images can be rotated electronically to produce a
constant orientation. For example, images of a left anterior
descending coronary can be electronically rotated so that the
circumflex is positioned at 9 o’clock. With this orientation,
the diagonal branches will arise from the left side of the
image; and the septal branches will appear perpendicular to
the diagonal branches. However, electronic rotation of the
image is an electronic aid to interpretation and not a
definitive standard. Side branches, visualized with both
angiography and ultrasound, are extremely useful as land-
marks in facilitating interpretation and comparisons. Some
authors also describe the use of perivascular landmarks as
important references for both axial position and tomo-
graphic orientation within the vessel. These landmarks
include the pericardium, strands of muscle tissue, and the
venous system.
V. CONTROLS FOR IMAGE ACQUISITION
System settings are very important in helping to interpret
plaque characteristics. A glossary of terms and their defini-
tions is appended.
A. Gain and TGC
Gain refers to amplification of the signal. Increasing the
overall gain can compensate for a low sensitivity catheter,
but at the expense of creating a more bistable (black and
white) image with increased noise and decreased gray scale
information.
Time gain compensation is a graduated adjustment of the
amplitude of the signal at predetermined distances from the
transducer, applied to balance intensity of the image, create
even gain throughout the image, and compensate for atten-
uation in the far field. Lowering of near field gain is
sometimes used to reduce near field artifacts or excessive
backscatter from blood, but it may also attenuate and
obscure signals from minimally reflective tissue (e.g., in-
stent neointimal hyperplasia). Time gain compensation
adjustments are specific only to certain mechanical scanners.
B. Compression and Rejection
There is no standard for setting the levels of compression
and rejection, therefore, operators should adjust the settings
until an optimal image with smooth gradation of gray levels
is obtained. Rejection and compression can easily be set too
high or too low, resulting in image artifacts. Rejection and
compression adjustments are specific only to certain me-
chanical scanners.
C. Time-Averaging and Persistence
The limited signal-to-noise ratio of IVUS images makes
them particularly amenable to noise reduction techniques.
Much of the noise in ultrasound is randomly distributed,
appearing as speckles in the image at different locations
within each successive frame, while real reflectors (tissue)
are present in the same location in consecutive frames.
Averaging of successive frames will reduce the apparent
intensity of noise; but it is always done at the expense of
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time resolution, and it may blur real targets. Therefore,
IVUS system designers commonly use a technique known as
“persistence,” in which the image represents mostly the
current frame (typically 60% to 90%) and a smaller percent-
age of the previous frame (10% to 40%). Thus, the displayed
image is a “moving average” that includes prior frames. This
technique can introduce objectionable motion artifacts.
D. Gamma Curves
Gamma curves control the relationship between the actual
and the displayed gray scale. They are used primarily to
present a more pleasing image, but they also affect dynamic
range and qualitative and quantitative characteristics. If they
are used excessively, gamma curve adjustments may result in
measurement inaccuracies.
VI. ACQUISITION AND DISPLAY TECHNIQUES
Current practice requires that the patient to be anticoagu-
lated, usually with heparin, before inserting the guidewire
into the coronary artery. Unless it is contraindicated, image
acquisition should be performed after administrating intra-
coronary nitroglycerin to avoid catheter-induced spasm.
A. Manual and Motorized Interrogation
There are two approaches to imaging: 1) motorized, or 2)
manual interrogation. In either case, imaging should include
careful uninterrupted imaging of the target segment, gen-
erally including at least 10 mm of distal vessel, the lesion
site(s), and the entire proximal vessel back to the aorta.
Many experts advocate that motorized transducer pullback be
performed at a speed of 0.5 mm/s. Faster pullback speeds
have the disadvantage of imaging focal pathology too
quickly, but they are commonly employed for longer extra-
cardiac vessels in order to minimize imaging times. Impor-
tant advantages of motorized interrogation include steady
catheter withdrawal to avoid imaging any segment too
quickly and the ability to concentrate on the images without
having to pay attention to catheter manipulation. Motorized
pullbacks permit length and volumetric measurements and
provide uniform and reproducible image acquisition for
multicenter and serial studies. However, inadequate exam-
ination of important regions of interest can occur because
the transducer does not remain for long at any specific site
in the vessel.
Manual transducer pullback should be performed slowly,
at a rate similar to motorized pullback. Advantages are the
ability to concentrate on specific regions of interest by
pausing the transducer motion at a specific location in the
vessel. Disadvantages include the possibility of skipping
over significant pathology by pulling the transducer too
quickly or unevenly and the inability to perform precise
length and volume measurements. Furthermore, antegrade
and retrograde manual catheter movement can be confusing
when the study is reviewed at a later date.
In interrogating aorto-ostial lesions it is important that
the guiding catheter be disengaged from the ostium. If it is
not, the true aorto-ostial lumen may be masked by the
catheter and, therefore, not identified.
B. Longitudinal Display (L-Mode)
An important limitation of IVUS is that only single cross-
sectional images of the coronary artery are displayed, limit-
ing spatial orientation and precluding facile assessment of
the length and distribution of plaque and lesions. Motorized
transducer pullback and digital storage of cross-sectional
images are necessary for longitudinal (L-mode) imaging. In
an L-mode display, computerized image reconstruction
techniques display sets of “slices” taken from a single cut
plane within each of a series of evenly spaced IVUS images
to approximate the longitudinal appearance of the artery (9).
To be meaningful, the cut plane should be through the
center of mass of the artery or of the lumen, not arbitrarily
through the center of the catheter, whose widely varying
position within the vessel can arbitrarily affect the appear-
ance of the artery.
There are major limitations of L-mode display, including
the obligate straight reconstruction of the artery and the
ability to display only a single arbitrary cut plane. Charac-
teristic motion artifacts result in a “saw-tooth” appearance
because of relative movement of the transducer and vessel,
although ECG-triggered image acquisition may eliminate
some of these artifacts (10,11). Excessive artifacts may result
in misinterpretations by inexperienced users. Therefore, the
L-mode should not be used for quantitative purposes.
C. Three-Dimensional Reconstruction
Three-dimensional reconstruction of IVUS involves the use
of advanced computer rendering techniques to display a
shaded or wire-frame image of the vessel and give the
operator a view of the vessel in its entirety (12,13). Although
many reconstruction algorithms are possible, all suffer from
major limitations. The localization of tissue interfaces (sur-
faces) by the computer software is inherently arbitrary; this
may or may not represent actual boundaries. Accordingly,
routine use of three-dimensional methods cannot be rec-
ommended, although such techniques are promising and
warrant future research.
D. Picture in a Picture Display
“Picture in picture” refers to the display of a fluoroscopic or
angiographic image as a small window within the IVUS
image. The major advantage of this approach is the ability to
relate the location of the transducer to the actual IVUS
images obtained at the site. A disadvantage is the relatively
low quality of small angiographic images recorded on
videotape and the difficulty in identifying the small trans-
ducer. In some systems, the angiographic image can be
displayed as the larger image and the IVUS as the small
window, but with similar disadvantages.
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VII. DEFINITION OF
“LESION” AND “REFERENCE” SEGMENT
Because coronary disease often appears to be more extensive
by IVUS than by angiography, there are several problems in
lesion and stenosis nomenclature (14–20). In some cases, a
vessel segment will contain diffuse atherosclerosis, but no
focal narrowings. In other cases, IVUS will reveal a number
of discrete focal narrowings and a few more severe stenoses.
Therefore, appropriate definitions of “lesion” and “reference
segment” nomenclature require different methodology than
commonly employed in angiography. Accordingly, for the
purpose of this document, the following definitions will be
used:
Proximal reference: The site with the largest lumen
proximal to a stenosis but within the same segment (usually
within 10 mm of the stenosis with no major intervening
branches). This may not be the site with the least plaque.
Distal reference: The site with the largest lumen distal to
a stenosis but within the same segment (usually within
10 mm of the stenosis with no intervening branches). This
may not be the site with the least plaque.
Largest reference: The largest of either the proximal or
distal reference sites.
Average reference lumen size: The average value of lumen
size at the proximal and distal reference sites.
Lesion: A lesion represents accumulation of atheroscle-
rotic plaque compared with a predefined reference.
Stenosis: A stenosis is a lesion that compromises the
lumen by at least 50% by cross-sectional area (CSA)
(compared with a predefined reference segment lumen).
Worst stenosis (T-1): The stenosis with the smallest
lumen size.
Secondary stenoses (T-2, T-3, etc.): Lesions meeting the
definition of a stenosis, but with lumen sizes larger than the
worst stenosis.
In some cases, proper description of lesions and stenoses
may require analysis of an entire segment with measurement
of a number of image slices. In other cases, lesions, and
especially stenoses, can be optimally represented by a single
slice. Within a segment, there will always be a worst stenosis
(T-1), but there can be multiple secondary stenoses (T-2,
T-3, etc.). The worst stenosis cross-sectional image should
be the slice with the smallest lumen, which may or may not
represent the site with the largest atheroma. This site may
differ slightly in location from its angiographic counterpart.
Pre- and post-intervention stenosis site selection and
measurements should be performed in an identical fashion,
recognizing that the exact location of the worst stenosis may
change. For certain serial studies, the same anatomic image
slice will be measured and compared (pre- vs. post-
intervention or post-intervention vs. follow-up), although it
may or may not represent the smallest lumen in both cases.
The following sequence can be used to identify image slices
on serial studies: 1) an image slice is selected from the first
study, and the distance from this image slice to the closest
identifiable axial landmark (a fiduciary point) is measured
(using seconds or frames of videotape); 2) the second study
is screened to identify this fiduciary point, and the previ-
ously measured distance is used to identify the correspond-
ing image slices on the second study; 3) vascular and
perivascular markings (e.g., small side branches, venous
structures, calcific and fibrotic deposits) are used to confirm
slice identification. If necessary, studies should be analyzed
side-by-side and the imaging runs studied frame-by-frame
to ensure that the same anatomic slices correspond correctly.
In order to assess the morphology of the lesion or stenosis
(i.e., the plaque composition, calcium, etc.), the entire lesion
or stenosis should be surveyed, not just the worst stenosis
image slice selected for measurement.
Efforts should be made to use the same reference sites
before and after intervention unless the reference site is
altered by an intervention during the procedure (i.e., incor-
porated into a stented or atherectomized segment).
In the case of multiple lesions within a single coronary
segment, distinct lesions or stenoses require at least 5 mm
between them. If not, then the disease should be considered
a single long lesion.
VIII. QUANTITATIVE MEASUREMENTS
Measurements should be avoided if artifacts such as NURD
are present or if the IVUS catheter is positioned obliquely
(not parallel to the vessel long axis). Area measurements can
be added to calculate volumes (Simpson’s Rule).
A. Border Identification
It is important to recognize that all ultrasound techniques,
including IVUS, require measurements to be performed at
the leading edge of boundaries, never the trailing edge (Fig.
1). With few exceptions, the location of the leading edge is
accurate and reproducible regardless of system settings or
image-processing characteristics of different ultrasound
scanners (21). Measurements at the trailing edge are incon-
sistent and frequently yield erroneous results.
In muscular arteries such as the coronary arteries, there
are frequently three layers (22–27). The innermost layer
consists of a complex of three elements: intima, atheroma
(in diseased arteries), and internal elastic membrane. This
innermost layer is relatively echogenic compared with the
lumen and media. The trailing edge of the intima (which
would correspond to the internal elastic membrane) cannot
always be distinguished clearly. Moving outward from the
lumen, the second layer is the media, which is usually less
echogenic than the intima. In some cases the media may
appear artifactually thin because of “blooming,” an intense
reflection from the intima or external elastic membrane
(EEM). In other cases the media can appear artifactually
thick because of signal attenuation and the weak reflectivity
of the internal elastic membrane. (In elastic arteries such as
the carotid artery, the media is more echoreflective because
of the higher elastin content.) The third and outer layer
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consists of the adventitia and periadventitial tissues. There is
no distinct boundary on IVUS images separating the true
adventitia from surrounding perivascular tissues.
B. Lumen Measurements
Lumen measurements are performed using the interface
between the lumen and the leading edge of the intima.
In normal segments, the intimal leading edge is easily
resolved because the intima has thickened enough to be
resolved as a separate layer and has sufficiently different
acoustic impedance from the lumen. Under such circum-
stances, the leading edge of the innermost echogenic layer
should be used as the lumen boundary. Occasionally,
particularly in younger normal subjects (e.g., post-
transplantation), the vessel wall will have a single-layer
appearance because the intima cannot be resolved as a
discrete layer. In such cases, a thin, inner echolucent band
corresponding to the intima and media is usually present
and it is this boundary that should be measured. While
Figure 1. Example of commonly performed direct and derived IVUS measurements. Panels A and B illustrate the reference segment, whereas panels C
and D represent the stenosis. In Panel B, the EEM and lumen areas are traced. In panel D, the minimum and maximum lumen diameters are illustrated
using a double headed arrow (open and solid arrowheads, respectively). In panel D, the minimum and maximum atheroma thickness is also illustrated
using double headed arrows (white for minimum and black for maximum). Also in panel D, the EEM and lumen areas are traced and the arc of
calcification (dotted line) is shown. EEM 5 external elastic membrane.
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lumen boundaries defined in this manner may include the
intima, the thickness of this layer will be ,160 mm and will
add negligible error to the lumen measurement.
Once the lumen border has been determined, the follow-
ing lumen measurements can be derived. In all cases
measurements are performed relative to the center of mass
of the lumen, rather than relative to the center of the IVUS
catheter:
Lumen CSA: The area bounded by the luminal border.
Minimum lumen diameter: The shortest diameter
through the center point of the lumen.
Maximum lumen diameter: The longest diameter
through the center point of the lumen.
Lumen Eccentricity: 1 [(maximum lumen diameter minus
minimum lumen diameter) divided by maximum lumen
diameter.]
Lumen area stenosis: (Reference lumen CSA minus
minimum lumen CSA)/reference lumen CSA. The refer-
ence segment used should be specified (proximal, distal,
largest, or average—see above).
Post-intervention (if dissection is present), it is important
to state whether the lumen area is the true lumen or a
combination of the true and false lumens.
C. EEM Measurements
A discrete interface at the border between the media and the
adventitia is almost invariably present within IVUS images
and corresponds closely to the location of the EEM. The
recommended term for this measurement is EEM CSA,
rather than alternative terms such as “vessel area” or “total
vessel area.”
External elastic membrane circumference and area cannot
be measured reliably at sites where large side branches
originate or in the setting of extensive calcification because
of acoustic shadowing. If acoustic shadowing involves a
relatively small arc (,90°), planimetry of the circumference
can be performed by extrapolation from the closest identi-
fiable EEM borders, although measurement accuracy and
reproducibility will be reduced. If calcification is more
extensive than 90° of arc, EEM measurements should not be
reported. In addition, some stent designs may obscure the
EEM border and render measurements unreliable.
Disease-free coronary arteries are circular, but atheroscle-
rotic arteries may remodel into a non-circular configuration.
If maximum and minimum EEM diameters are reported,
measurements should bisect the geometric center of the
vessel rather than the center of the IVUS catheter.
D. Atheroma Measurements
Because the leading edge of the media (the internal elastic
membrane) is not well delineated, IVUS measurements
cannot determine true histological atheroma area (the area
bounded by the internal elastic membrane) (21). Accord-
ingly, IVUS studies use the EEM and lumen CSA mea-
surements to calculate a surrogate for true atheroma area,
the plaque plus media area. In practice, the inclusion of the
media into the atheroma area does not constitute a major
limitation of IVUS, because the media represents only a very
small fraction of the atheroma CSA. We suggest that the
term “plaque plus media (or atheroma)” be used and that the
following measurements be performed:
Plaque plus media (or atheroma) CSA: The EEM CSA
minus the lumen CSA.
Maximum plaque plus media (or atheroma) thickness: The
largest distance from the intimal leading edge to the EEM
along any line passing through the center of the lumen.
Minimum plaque plus media (or atheroma) thickness: The
shortest distance from intimal leading edge to the EEM
along any line passing through the luminal center of mass.
Plaque plus media (or atheroma) eccentricity: (Maximum
plaque plus media thickness minus minimum plaque plus
media thickness) divided by maximum plaque plus media
thickness.
Plaque (or atheroma) burden: Plaque plus media CSA
divided by the EEM CSA. The atheroma burden is distinct
from the luminal area stenosis. The former represents the
area within the EEM occupied by atheroma regardless of
lumen compromise. The latter is a measure of luminal
compromise relative to a reference lumen analogous to the
angiographic diameter stenosis.
E. Calcium Measurements
Intravascular ultrasound is the most sensitive in vivo method
for the detection of coronary calcium (28,29). Calcific
deposits appear as bright echoes that obstruct the penetra-
tion of ultrasound, a phenomenon known as “acoustic
shadowing.” Because high frequency ultrasound does not
penetrate the calcium, IVUS can detect only the leading
edge and cannot determine the thickness of the calcium.
Calcium can also produce reverberations or multiple reflec-
tions that result from the oscillation of ultrasound between
transducer and calcium and cause concentric arcs in the
image at reproducible distances.
Calcium deposits are described qualitatively according to
their location (e.g., lesion vs. reference) and distribution:
Superficial: The leading edge of the acoustic shadowing
appears within the most shallow 50% of the plaque plus
media thickness.
Deep: The leading edge of the acoustic shadowing ap-
pears within the deepest 50% of the plaque plus media
thickness.
The arc of calcium can be measured (in degrees) by using
an electronic protractor centered on the lumen. Because of
beam-spread variability at given depths within the transmit-
ted beam, this measurement is usually valid only to 615°.
Semi-quantitative grading has also been described, which
classifies calcium as absent or subtending 1, 2, 3, or 4
quadrants. The length of the calcific deposit can be mea-
sured using motorized transducer pullback.
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F. Stent Measurements
Metallic stent struts are strong reflectors of ultrasound and,
therefore, appear as echogenic points or arcs along the
circumference of the vessel. Depending on the design, each
stent has a slightly different appearance. Slotted-tube or
multicellular stents appear as focal metallic points, whereas
coiled stents appear as arcs of metal that subtend small
sections of the vessel wall.
Strut apposition refers to the proximity of stent struts to
the arterial wall (30–32). Good apposition is defined as
sufficiently close contact to preclude blood flow between any
strut and the underlying wall. Documentation of non-
apposition can be enhanced by flushing saline or contrast
from the guiding catheter to confirm the presence or
absence of flow. The arc and/or length of non-apposition
can be reported.
In imaging stents by IVUS, high gain settings should be
avoided because the metallic struts are strong ultrasound
reflectors and easily create side lobes (see Technical Glos-
sary). Side lobes may obscure the true lumen and stent
borders, interfering with area measurements and the assess-
ment of apposition, dissection, etc. The stent area is
measured by planimetry of the area bounded by the stent
struts. If strut non-apposition is present, the stent area will
be smaller than the lumen area. In the case of previously
placed stents with superimposed neointimal proliferation,
the stent area will be larger than the lumen area.
The following measurements are commonly reported:
Stent CSA: The area bounded by the stent border.
Minimum stent diameter: The shortest diameter through
the center of mass of the stent.
Maximum stent diameter: The longest diameter through
the center of mass of the stent.
Stent symmetry: [(maximum stent diameter minus min-
imum stent diameter) divided by maximum stent diameter.]
Stent expansion: The minimum stent CSA compared
with the predefined reference area, which can be the
proximal, distal, largest, or average reference area.
G. Reference Segment Measurements
Once the reference segments are selected, quantitative and
qualitative assessment should be similar to the stenosis and
include EEM, lumen, and plaque plus media measure-
ments.
H. Remodeling
Vascular remodeling, originally described by Glagov et al.
(33) from necropsy specimens, refers to the increase or
decrease in EEM area that occurs during the development
of atherosclerosis. By facilitating both the plaque and EEM
area measurements, IVUS imaging permits in vivo assess-
ment of vascular remodeling (34–40).
If EEM area increases during atheroma development, the
process is termed “positive remodeling.” If the EEM de-
creases, the process is termed “negative” or “constrictive
remodeling.” In positive remodeling, the EEM area increase
may over-compensate for increasing plaque area, resulting in
an net increase in lumen size. Alternatively, remodeling can
either: 1) exactly compensate for increasing plaque area,
resulting in no change in lumen size, or 2) under-
compensate for increasing plaque area, often termed inad-
equate remodeling.
An index that describes the magnitude and direction of
remodeling is expressed as: lesion EEM CSA/reference
EEM CSA. If the lesion EEM area is greater than the
reference EEM area, positive remodeling has occurred, and
the index will be .1.0. If the lesion EEM area is smaller
than the reference EEM area, negative remodeling has
occurred, and the index will be ,1.0. A number of dichot-
omous definitions of remodeling have been proposed (34–
40). The reference segment(s) used in studies of remodeling
should be measured without any major intervening side
branches. This relationship defines remodeling according to
a comparison of the reference EEM and the lesional EEM.
However, both reference and lesion sites may have under-
gone changes in EEM area during the atherosclerotic
disease process. Accordingly, the evidence of remodeling
derived from this index is indirect.
Direct evidence of remodeling can be derived only from
serial changes in the EEM CSA that have been determined
by two or more measurements obtained at different times. In
this case, the slope of the line relating the change in EEM
area to the change in plaque plus media (atheroma) area
determines the direction and magnitude of remodeling. A
slope .1.0 would indicate positive remodeling; whereas a
slope ,1.0 would indicate inadequate (incompletely com-
pensatory) remodeling, a slope ,0 (or reduction in EEM
CSA) would indicate negative or constrictive remodeling.
Only direct evidence of remodeling (serial 2 post-
intervention vs. follow-up measurements of EEM CSA or
volume), not indirect indices, should be employed in studies
of the restenotic process.
I. Length Measurements
Length measurements using IVUS can be performed using
motorized transducer pullback (number of seconds 3 pull-
back speed). This approach can be used to determine the
length of a lesion, stenosis, calcium, or any other longitu-
dinal feature.
IX. QUALITATIVE ASSESSMENT
A. Atheroma Morphology
Ultrasound images are fundamentally different from histol-
ogy. Intravascular ultrasound cannot be used to detect and
quantify specific histologic contents.
Soft (echolucent) plaques: The term “soft” refers not to the
plaque’s structural characteristics, but rather to the acoustic
signal that arises from low echogenicity. This is generally
the result of high lipid content in a mostly cellular lesion
(23–27,41,42). However, a zone of reduced echogenicity
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may also be attributable to a necrotic zone within the
plaque, an intramural hemorrhage, or a thrombus. Most soft
plaques contain minimal collagen and elastin.
Fibrous plaques: These plaque have an intermediate
echogenicity between soft (echolucent) atheromas and
highly echogenic calcific plaques (23–27,41,42). Fibrous
plaques represent the majority of atherosclerotic lesions. In
general, the greater the fibrous tissue content, the greater
the echogenicity of the tissue. Very dense fibrous plaques
may produce sufficient attenuation or acoustic shadowing to
be misclassified as calcified.
Calcific: See section on calcium measurements.
Mixed: Plaques frequently contain more than one acous-
tical subtype. Appropriate terminology for these plaques
includes a number of descriptions such as “fibrocalcific,”
“fibrofatty,” etc.
Thrombus: By IVUS, a thrombus is usually recognized as
an intraluminal mass, often with a layered, lobulated, or
pedunculated appearance (43,44). Thrombi may appear
relatively echolucent or have a more variable gray scale with
speckling or scintillation. Blood flow in “microchannels”
may also be apparent within some thrombi. Stagnant blood
flow can simulate a thrombus with a grayish-white accumu-
lation of specular echoes within the vascular lumen. Injec-
tion of contrast or saline may disperse the stagnant flow,
clear the lumen, and allow differentiation of stasis from
thrombosis. However, none of these features is patho-
genomic for thrombus, and the diagnosis of thrombus by
IVUS should always be considered presumptive.
Intimal hyperplasia: The intimal hyperplasia characteris-
tic of early in-stent restenosis often appears as tissue with
very low echogenicity, at times less echogenic than the
blood speckle in the lumen. Appropriate system settings are
critical to avoid suppressing this relative non-echogenic
material. The intimal hyperplasia of late in-stent restenosis
often appears more echogenic.
B. Dissections and Other Complications After Intervention
Intravascular ultrasound is commonly employed to detect
and direct the treatment of dissections and other complica-
tions after intervention (45–49). The classification of dis-
sections into five categories is recommended:
Intimal: Limited to the intima or atheroma, and not
extending to the media.
Medial: Extending into the media.
Adventitial: Extending through the EEM.
Intramural hematoma: An accumulation of blood within
the medial space, displacing the internal elastic membrane
inward and EEM outward. Entry and/or exit points may or
may not be observed.
Intra-stent: Separation of neointimal hyperplasia from
stent struts, usually seen only after treatment of in-stent
restenosis.
The severity of a dissection can be quantified according
to: 1) depth (into plaque—useful only in describing intimal
dissections that do not reach the media); 2) circumferential
extent (in degrees of arc) using a protractor centered on the
lumen; 3) length using motorized transducer pullback; 4)
size of residual lumen (CSA); and 5) CSA of the luminal
dissection. Additional descriptors of a dissection may in-
clude the presence of a false lumen, the identification of
mobile flap(s), the presence of calcium at the dissection
border, and dissections in close proximity to stent edges.
In a minority of patients, the dissection may not be
apparent by IVUS, because of the scaffolding by the imaging
catheter or because the dissection is located behind calcium.
Usually, ultrasound occult dissections can be demonstrated
by angiography.
C. Unstable Lesions and Ruptured Plaque
No definitive IVUS features define a plaque as vulnerable
(38,44). However, necropsy studies demonstrated that un-
stable coronary lesions are usually lipid-rich with a thin
fibrous cap. Accordingly, hypoechoic plaques without a
well-formed fibrous cap are presumed to represent poten-
tially vulnerable atherosclerotic lesions.
Ruptured plaques have a highly variable appearance by
IVUS. In patients studied after an acute coronary syndrome,
ultrasound imaging may reveal an ulceration, often with
remnants of the ruptured fibrous cap evident at the edges of
the ulcer. A variety of other appearances are common,
including fissuring or erosion of the plaque surface. The
following definitions are recommended:
Plaque ulceration: A recess in the plaque beginning at the
luminal-intimal border, typically without enlargement of
the EEM compared with the reference segment.
Plaque rupture: A plaque ulceration with a tear detected
in a fibrous cap. Contrast injections may be used to prove
and define the communication point.
The presence of thrombi may obscure IVUS detection of
plaque fissuring or ulceration.
D. Unusual Lesion Morphology
(Aneurysms, Pseudoaneurysms, True vs. False Lumen)
True aneurysm: A lesion that includes all layers of the
vessel wall with an EEM and lumen area .50% larger than
the proximal reference segment.
Pseudoaneurysm: Disruption of the EEM, usually ob-
served after intervention.
True versus false lumen: A true lumen is surrounded by
all three layers of the vessel-intima, media, and adventitia.
Side branches communicate with the true, but not with the
false lumen. A false lumen is a channel, usually parallel to
the true lumen, that does not communicate with the true
lumen over a portion of its length.
E. Ambiguous Lesions
Angiographically ambiguous lesions may include: 1) inter-
mediate lesions of uncertain stenotic severity; 2) aneurysmal
lesions; 3) ostial stenoses; 4) disease at branching sites; 5)
tortuous vessels; 6) left main stem lesions; 7) sites with focal
spasm; 8) sites with plaque rupture; 9) dissection after
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coronary angioplasty; 10) intraluminal filling defects; 11)
angiographically hazy lesions; and 12) lesions with local flow
disturbances.
Intravascular ultrasound is frequently employed to exam-
ine lesions with the above characteristics, in some cases
providing additional evidence useful in determining
whether the stenosis is clinically significant (i.e., difficult to
assess left main or borderline stenosis with continued
symptoms). However, it must be emphasized that IVUS
does not provide physiologic information per se.
F. Special Disease Considerations
1. Assessment of transplant vasculopathy. Coronary dis-
ease represents the major cause of death after the first year
following transplantation and is often clinically silent be-
cause the heart is denervated. Ischemia by functional testing
does not usually occur until the disease is advanced. Tradi-
tionally, angiography has been performed annually for
surveillance, but the diffuse nature of the disease impairs
detection. Accordingly, IVUS has emerged as the optimal
method for early detection (50–53).
The definition of abnormal intimal thickness is contro-
versial because the categorical classification of the continu-
ous variable, intimal thickness, into normal or abnormal is
inherently arbitrary. Most ultrasound studies define the
threshold for transplant vasculopathy as an intimal thickness
.0.5 mm.
Intravascular ultrasound protocols use a variety of ap-
proaches in the sampling of the coronary tree to detect
transplant vasculopathy. Some centers randomly examine
three or four sites at least 1 cm apart, but this method is
limited by sampling errors and selection bias and is not
suitable for serial analysis. Other approaches include site
selection using predefined criteria to provide equal repre-
sentation from each coronary segment. This usually captures
the most severe intimal thickening, but it is also limited by
selection bias. The most rigorous approach uses automated
pullback to determine the entire volume of the EEM,
lumen, and intima. This is labor-intensive but, if performed
carefully, is the most accurate.
All the above methodologies have been used to compare
follow-up and baseline studies. Serial images are often
compared side by side, with angiographic and IVUS land-
marks (side branches, pericardium, and cardiac veins) used
to match sites. Alternatively, motorized pullback sequences
can be compared, but some site matching is usually required
because the fiduciary points are often slightly different in
sequences from various time points.
2. Serial examination of progression/regression. Angio-
graphic studies of the regression/progression of atheroscle-
rosis have generally shown minimal changes in luminal
dimensions after anti-atherosclerotic treatment. Intravascu-
lar ultrasound, by virtue of its ability to depict the vessel
wall, may be ideally suited for atherosclerosis regression/
progression studies. Intravascular ultrasound often detects a
much larger extent of disease than is evident by angiogra-
phy, frequently showing atherosclerosis in virtually all slices
in pullbacks performed in patients with only a few stenoses
(20).
Several large IVUS regression/progression studies are
currently underway. Nearly all employ similar methodology.
A target segment of a vessel is identified, and the ultrasound
catheter is placed distal to a fiduciary point such as a
coronary branch. A motorized pullback is performed, typi-
cally at 0.5 mm/s. Using the fiduciary side branch as the
starting point, a long segment of vessel (25 to 50 mm) is
analyzed, measuring the EEM, lumen, and plaque plus
media area. Because a long pullback will contain at least
1,000 frames, analysis routinely subsamples at predefined
intervals, typically every 1 mm. Studies show that plaque
plus media volume calculated in this manner is highly
reproducible and that serial studies can detect very small
changes in atheroma volume.
3. Aortic, carotid, and peripheral vascular disease. An-
giography has several unique limitations in defining the
anatomy of peripheral vessels (54). Often, angulated or
orthogonal views are not possible, foreshortening is not
apparent and heavy calcification in arteries deep within the
thorax, abdomen, pelvis, and thigh can obscure the vessel
borders even after digital subtraction. The discovery of
angiographically occult lesions by IVUS is common. There
is often great disparity in size between large peripheral
vessels and the relatively small angiographic catheters,
which magnifies minor errors in calibration of radiographic
measurements.
Analysis of IVUS in non-coronary vessels is similar to
that of coronary arteries. Selection of catheter size, fre-
quency, and type (mechanical or phased array) is based on
the size and location of the vessel(s) to be examined and the
size of the access sheath or guiding catheter. Unlike the
coronary arteries in which near field resolution is the most
crucial, the larger and more variable sizes of peripheral
vessels make far field resolution equally important. In
practice, lesion and reference sites are identified, assessed,
and measured pre- and post-intervention similarly to coro-
nary applications. The information is used to select appro-
priate devices and confirm results. The presence of diffuse
disease, particularly common in the peripheral vasculature,
may preclude identification of a truly “normal” reference
site.
Several IVUS artifacts or limitations are more prominent
in peripheral applications, particularly catheter obliquity.
Other important problems include limited spatial resolution
in very large vessels and severe acoustic shadowing by
calcific plaque.
4. Interventional target lesion assessment. Target lesions
can be assessed pre-intervention, sequentially during the
procedure, post-intervention, and at follow-up (55,56).
However, the axial location of the smallest target site may
shift during each of these time points. If image slices do not
have the same axial locations on sequential studies, it may be
difficult to distinguish the effects of the intervention, plaque
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distribution and remodeling, and shifting of plaque during
the procedure. Planar analysis of only the smallest target site
alone, before and after intervention, can produce the false
impression of plaque compression or reduction. Volumetric
analysis and averaging of multiple image slices (the sites
with the smallest lumen at each time point) are both
methods of compensating for the “migration” of the mini-
mum lumen area. If only one target site is measured, its
location should be specified. This is best accomplished by
measuring the distance from a nearby well-identified axial
landmark (i.e., side branch or unique calcium deposit) or by
using vascular or perivascular markings.
5. The restenotic lesion. The restenotic lesion is the
stenosis within the treated zone with the smallest lumen
area at follow-up (55,56). The axial position of the rest-
enotic lesion is usually different from the smallest pre-
intervention or post-intervention target site. Thus, the
image slice with the smallest luminal dimensions of the
restenotic lesion cannot be directly compared to the image
slice with the smallest lumen dimensions pre- or post-
intervention. In-stent restenotic lesions require special con-
sideration. The smallest lumen and the smallest stent area
should be measured, but these may not be at the same axial
location within the stented segment; and, in fact, the
minimum lumen area may lie outside the stent.
To assess the restenotic process, the image slice with the
smallest lumen area at follow-up is identified and compared
with the same image slice on the post-intervention and
pre-intervention studies, using measurements from a fidu-
ciary point or by identifying vascular or perivascular mark-
ings. Volumetric analysis of a length of arterial segment that
encompasses all three locations (pre-, post- and restenotic)
may also be useful in some situations. Three basic measure-
ments in non-stented lesions are commonly reported—
absolute values and change in the EEM, lumen, and plaque
plus media areas or volumes. In stented lesions, at least two
measurements are employed—absolute values of, and
change in, stent and luminal dimensions. (Implantation of a
stent can often obscure the measurement of EEM areas
within the stented segment.) There can be changes in
reference segment dimensions. Reference segment image
slices with the same axial location on the serial studies
should be identified for comparative analysis. (See earlier
text for definitions of Reference Segments.)
6. Vein graft disease. In vein grafts, wall morphology and
plaque characteristics are different from those in native
coronary arteries. The bypass graft wall is free from the
surrounding tissue and has no side branches. In situ veins do
not have an EEM. However, vein grafts typically undergo
“arterialization” with morphologic changes that include
intimal fibrous thickening, medial hypertrophy, and lipid
deposition. The EEM area is measured by tracing the outer
border of the sonolucent zone. All other measurements
including plaque plus media area and plaque burden, are
calculated in a similar fashion to native coronary disease.
7. Serial stent studies. Serial studies (post-intervention vs.
follow-up) can assess the mechanisms of in-stent restenosis,
including the contributions of intimal hyperplasia and
chronic stent recoil (57,58). Using automated pullback, the
entire stent, lumen, and intimal hyperplasia (stent minus
lumen) volumes are calculated post-implantation and at
follow-up. The distribution of neointima can be analyzed by
plotting intimal hyperplasia area over the length of the stent.
Using planar analysis, late luminal loss can be measured
by comparing the minimum lumen CSA post-implantation
and at follow-up. Chronic stent recoil can be measured by
comparing the minimum stent CSA post-implantation with
follow-up values. There can also be changes in reference
segment dimensions. Reference segment image slices with
the same axial location on the serial studies should be
identified for comparative analysis. The distribution of
reference segment changes (EEM, plaque plus media, and
lumen areas) can be analyzed by plotting these parameters
over the length of the reference segment that is contiguous
with the stent edge.
8. Radiation. Intravascular ultrasound can be used to study
the mechanisms and results of strategies for reducing
restenosis, including brachytherapy (59). In non-stented
lesions, serial (post-radiation vs. follow-up) analysis of
lesion site and reference segment EEM, lumen, and plaque
plus media volume is the most accurate approach. In stented
lesions, measurements should include serial (post-radiation
vs. follow-up) volumetric analysis of the stent, lumen, and
intimal hyperplasia volumes and, where possible, measure-
ment of serial analysis of EEM volumes as well. In addition,
reference segment EEM, lumen, and plaque plus media
volumes should be analyzed because radiation may affect
these “non-treated” segments. The distribution of the neo-
intima can be analyzed by plotting the intimal hyperplasia
CSA over the length of the stent. Edge effects can be
assessed by plotting changes in stent, lumen, and intimal
hyperplasia CSA within the stent and changes in reference
EEM, lumen, and plaque plus media area versus length.
Qualitative morphology (i.e., apposition, dissections, etc.)
should also be reported. The potential role of IVUS for
dosimetry has not been defined and may depend on the
radiation source.
X. SPECIALIZED ANALYSIS TECHNIQUES
A. Radiofrequency–Backscatter
Analysis of the raw radiofrequency (RF) data is a technique
for assessing tissue properties (60). Among the various
analysis parameters, the envelope of the RF signal is most
commonly used for conventional image presentation. When
the reflected ultrasound signal is analyzed in terms of its
frequency components, a power spectrum results. This
represents the magnitudes of all the frequencies within the
returned signal. In vitro studies suggest that a detailed
analysis of backscattered RF data may offer an objective and
reproducible method of categorizing wall morphology and
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plaque components. It remains uncertain whether spectral
analysis of unprocessed data is reliable and unaffected by the
various sources of error during in vivo imaging (angle
dependency, blood noise) and should be considered a
research tool.
B. Automated Edge Detection
The main objective of automated edge detection in IVUS
imaging is to extract the relevant structural surface infor-
mation such as lumen-intima border and/or media-
adventitia border (10). This process includes the enhance-
ment of image features and segmentation (separation of the
image into its constituent parts). The gray level of a single
pixel does not have sufficient information to assign that pixel
to a structure. Therefore, the analysis of the spatial distri-
bution of gray levels (multiple pixels and sub-images) is
required for edge detection, but no method has found
widespread acceptance. Edge detection and textural analysis
should be considered as research tools, and they always
require visual confirmation.
XI. REPORTING OF IVUS STUDIES
A. Recommended Format and
Minimum Content of Coronary IVUS Reports
A written report for the IVUS examination should be
generated. The report helps to communicate relevant infor-
mation and becomes an important part of the patient’s
medical record where it may pertain to clinical, legal, or
fiscal issues. Although the length and complexity of the
report will vary greatly depending on the needs of different
operators and institutions, a minimum content should be
included:
1) Appropriate patient demographic information and
date—reference to the accompanying angiographic
and/or interventional report;
2) The indication for the procedure;
3) Brief description of the IVUS procedure, including the
equipment used, the level of anticoagulation achieved,
and the coronary arteries imaged;
4) Basic findings of the IVUS pullback, including any
measurements that were performed such as minimum
lumen diameter, minimum stent area, or plaque burden;
5) Any notable morphological plaque features such as
dissection, calcium, or thrombus;
6) Changes in therapy that resulted from the information
provided by IVUS; and
7) IVUS-related complications and any consequent therapy.
A more complete report should also include the analysis of
three cardinal image slices—a distal reference segment, a
worst target site, and a proximal reference segment. Lumen
and EEM areas, calculated plaque plus media area, plaque
burden, and area stenosis should be reported. If a stent is
present, minimum stent area, an index of stent symmetry,
and a description of strut apposition should be included.
TECHNICAL GLOSSARY
Aperture: The active part of the transducer that emits
and/or receives ultrasound waves. Resolution and near field
size can be directly related to the aperture; with increasing
aperture size, the near field can be longer, thereby improving
the axial resolution.
Blood speckle: The ultrasound reflection from aggre-
gated blood cells.
Compress: A control that regulates the dynamic com-
pression and affects gray scale and overall gain. In general,
the higher the compression setting, the more black and
white the image will appear.
Diffraction: The bending of waves around edges.
Dynamic range: The range of gray scale that is displayed
between the weakest and the strongest targets. It is usually
expressed in decibels (dB). A large or broad dynamic range
is a favorable image characteristic. The dynamic range for
IVUS is typically 17 to 55 dB.
Echogenicity: The tendency of a tissue to reflect ultra-
sound. The higher the echogenicity, the brighter the tissue
will appear.
Far field: The region where the ultrasound beam diverges
and resolution decreases.
Frequency: The number of sound cycles in a given time
period. Frequency is inversely related to wavelength. Ultra-
sound waves with higher frequency (shorter wavelengths)
are reflected from smaller objects. A higher frequency
ultrasonic beam has greater resolution; but because a larger
percentage of higher-frequency ultrasound is reflected, pen-
etration decreases.
Gray scale: The ability of a system to record both bright
and weak echoes in varying shades of gray. The number of
gray scale levels is a measure of the dynamic range.
Integrated backscatter: Power (amplitude) measure-
ments of the received backscatter signal.
Near field: The zone where the beam width is approxi-
mately the same as the transducer diameter, resulting in
optimal resolution.
Rejection: A means of eliminating noise from the image
by filtering low-amplitude signals.
Reverberations: An artifact represented by secondary,
false echoes of the same structure. This gives the false
impression of a second interface twice as far from the
transducer as the first structure.
Radiofrequency (RF): Data after being converted from
ultrasound to electrical signals, but before being processed,
are in the RF range of electromechanical energy. Analysis of
RF signals may give rise to tissue characterization in IVUS.
Resolution: The ability to discriminate or identify two
objects that are close together.
Shadowing: An artifact representing weakness or absence
of signals located beyond structures (e.g., calcium, stent
struts) with high echo-reflectivity. This artifact can hinder
imaging beyond strong reflectors.
Side lobes: Extraneous beams of ultrasound that are
1490 Mintz and Nissen et al. JACC Vol. 37, No. 5, 2001
ACC Clinical Expert Consensus Document on IVUS April 2001:1478–92
generated from the edges of the individual transducer
elements and are not in the direction of the main ultrasonic
beam.
Tissue characterization: An approach that uses ultra-
sound to identify the physiologic and/or pathologic compo-
sition of biological tissue.
Ultrasound: Sound waves having a frequency .20,000
cycles per second (i.e., above the audible range). For medical
diagnostic purposes, ultrasound frequencies in the range of
millions of cycles per second (MHz) are used.
Velocity: The velocity at which sound travels through
human soft tissue; this is fairly constant at approximately
1,540 m/s.
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